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CC BY-NC-ND license (http://creativeBackground: Nontyphoidal Salmonella (NTS) is an important bacterial etiology of diarrheal dis-
ease, and it causes invasivediseases in immunocompromisedhosts. Forbacteremia fromsomespe-
cies, blood culture with a rapid time to positivity (TTP) is associated with greater mortality. This
study investigatedTTPofNTSbacteremia and its relationship to clinical parameters andprognosis.
Methods: Adult patients with NTS bacteremia who were admitted to a tertiary care facility in
northern Taiwan from January 2010 to December 2012 were enrolled. Demographics, clinical
andmicrobiological characteristics, and treatment responsewere reviewed. The TTP for each pa-
tient was retrieved from the automated machine.
Results: Sixty-six adult patients (mean age, 66.1 years; range, 27e96 years) with NTS bacteremia
were identified by the following serogroup distributions: serogroup B (23.4%), serogroupC1 (1.6%),
serogroup C2 (6.3%), and serogroup D (68.8%). The in-hospital mortality, 14-day mortality, and
30-day mortality were 15.2%, 7.6%, and 12.1%, respectively. The TTP ranged 6.5e41.7 hours (me-
dian: 11.5 hours). Patients with rapid TTP (less than 10 hours), compared to patientswithout rapid
TTP, were more likely to have liver cirrhosis (31.6% vs. 6.4%, pZ 0.013), endovascular lesions
(21.1% vs. 4.3%, pZ 0.05), higher bacteremia score, intensive care unit admission (57.9% vs.
25.5%, pZ 0.021), and septic shock (63.2% vs. 12.8%, p< 0.001). There were no significant differ-
ences in the in-hospital mortality and 14-day mortality between patients with TTP<10 hours and
patients with TTP 10 hours.
Conclusion: The TTP of blood cultures, interpreted with a cut-off point of <10 hours, in patients
with NTS bacteremia may provide useful diagnostic and prognostic information.
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418 H.-W. Lin et al.IntroductionNontyphoidal Salmonella (NTS), a cause of food-borne in-
fections, is an important bacterial etiology of diarrheal
disease. Most patients with NTS infections have self-limited
gastroenteritis, although invasive disease with bacteremia
occurs in 3e8% of patients.1 A nontyphoidal Salmonella
infection may also manifest as an extraintestinal infection
such as endovascular infection, meningitis, pneumonia,
septic arthritis, or osteomyelitis, either as a primary in-
fectious focus or secondary to primary bacteremia.2,3
Numerous factors affect the incidence of bacteremia such
as Salmonella serotype, geographic location, season, and
patient characteristics. Previous studies report that several
patient characteristics increase the risk of salmonellosis such
as extreme age of being in a chronic or immunosuppressed
state due to malignancy, rheumatological disease, tumor
necrosis factor (TNF) blockade, human immunodeficiency
virus (HIV) infection, or congenital immune defects.4e8 A
study in Taiwan reported that solid organ malignancy, age,
and extraintestinal infection were independent predictors
for in-hospital death among patients with NTS bacteremia.9
A previous study suggested that the severity of Gram-
negative bacilli bacteremia, as determined by quantitative
blood culture, may be correlated with mortality.10 How-
ever, quantitative blood cultures are not performed
routinely in clinical practice. Time to positivity (TTP) for a
given microorganism, as assessed by automated blood cul-
ture processing devices, depends on the bacterial inoc-
ulum,11 which may be influenced by the source of infection,
the presence of antimicrobial agents,12 and the patient’s
clinical characteristics.
Previous studies have shown that a rapid TTP is associ-
ated with a significantly greater mortality risk in patients
infected with Staphylococcus aureus13,14 and Klebsiella
pneumoniae bacteremia.15 Rapid TTP is also an indepen-
dent predictor of fatal outcome in patients with diverse-
source Escherichia coli bacteremia,16 and it is a marker of
severe sepsis or shock and meningitis in individuals with
bacteremia caused by Streptococcus pneumoniae.17 How-
ever, TTP and the variables associated with it have only
been evaluated for a limited number of bacterial species.
There is little information regarding the association of TTP
with clinical parameters in patients with Salmonella
bacteremia.18,19 The present study accordingly investigated
the TTP in patients with NTS bacteremia and the relation-
ship of TTP with clinical parameters and prognosis.
Materials and methods
Setting and patients
This study was conducted at the Far Eastern Memorial
Hospital, a 1040-bed tertiary care facility in northern
Taiwan (New Taipei City). The methodology of the study
followed the previous work of the corresponding author as a
model.15 From January 2010 to December 2012, patients
with NTS bacteremia were identified by central laboratory
personnel. Enrolled patients were diagnosed as having NTS
bacteremia. The TTP for each patient was retrieved from
the hospital’s automated blood culture instrument (see the“TTP of blood cultures” section later). Each patient was
included only once, at the time of the first bacteremia.
Patients younger than 20 years, patients with polymicrobial
bacteremia, and patients who were not admitted to the
hospital were excluded. The following data were recorded
for each patient: age, sex, underlying illness and associated
Charlson Comorbidity Index,20 location of care in the hos-
pital, and severity of bacteremia, as determined by the
Pittsburgh bacteremia score.21 The primary outcome mea-
sure was the association of TTP with in-hospital mortality.
Secondary analyses determined the associations between
TTP with age, underlying diseases, severity of illness,
source of infection, intensive care unit (ICU) admission, and
14-day and 30-day mortality.
TTP of blood cultures
Two sets of blood samples (10mL each) were generally taken
from separate locations, inoculated into aerobic and anaer-
obic culture flasks, and then incubated using the BACTEC
9240 automated detection blood culture system (Becton
Dickinson Diagnostic Instrument Systems, Sparks, MD, USA).
All bottles were loaded when they were received in the
central laboratory. The BACTEC 9240 system (Becton Dick-
inson Diagnostic Instrument Systems) continuously monitors
carbon dioxide (CO2) production every 10 minutes, and in-
dicates positivity by a fluorescent signal. All positive blood
samples were subcultured and bacterial isolates were iden-
tified, according to the BD Phoenix automated microbiology
systemand conventional biochemicalmethods.22 Serogroups
of Salmonella isolates were examined with O antisera using
the slide agglutination method. Antimicrobial susceptibil-
ities were determined using the disk-diffusion method. The
interpretation of susceptibility data followed the criteria of
the Clinical Laboratory Standard Institute (CLSI).23 Isolates in
the “intermediate” category were considered resistant.
The TTP, defined as the time from the start of incubation
to the start of an alert signal (documented by the BACTEC
9240 system), was recorded for each blood culture. When
multiple cultures were positive, the shortest TTP was used
for analysis.
Definitions
The clinical course and primary site of infection were
determined from information supplied by primary care
physicians and medical records. The infection focus of
bacteremia was determined clinically by the presence of an
active infection site concomitant with NTS bacteremia, or by
isolation of an identical organism from clinical specimens
other than blood. A urinary tract infection (UTI) was defined
as a positive urine culture and pyuria. Enteritis was defined
as a positive stool culture and diarrhea. Intra-abdominal
infection included all infections within the abdomen, except
enteritis. If no infection focus could be identified, the
bacteremia was classified as primary. Septic shock is iden-
tified in accordance with the Surviving Sepsis Campaign
criteria.24 The study population was divided into two groups:
(1) patients with rapid TTP (less than10 hours) and (2) pa-
tients with slow TTP (10 hours or greater), based on the re-
sults of univariate analyses, which showed that a TTP cut-off
TTP in non-typhoidal Salmonella bacteremia 419point of <10 hours had the highest odds ratio (OR) (TTP cut-
off pointZ 9, ORZ 1.78; cut-off pointZ 10, ORZ 1.82; cut-
off pointZ 11, ORZ 1.63; cut-off pointZ 12, ORZ 0.97).
Statistical analysis
The demographic and clinical characteristics of patients in
the two groups were initially compared using univariate
analysis. Continuous variables are expressed as the
means  the standard deviations and were compared using
the ManneWhitney test. Categorical variables are expressed
as the number and percentage and were compared using the
Chi-square test or the Fisher’s exact test. Univariate anal-
ysis was used to assess the associations between risk factors
and in-hospital mortality. Variables that were significant in
the univariate analysis (p < 0.1) were then entered into a
multivariate model. The ORs and corresponding 95% confi-
dence intervals (CIs) were calculated. Cumulative survival
after the day of blood sample collection until day 30 was
calculated by the KaplaneMeier method and the mortality
rates of the two groups are shown. A value of p < 0.05 was
significant. In addition, the potential factors associated with
the 30-day mortality of patients with NTS bacteremia were
examined by the Cox proportional hazards regression anal-
ysis. Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS) software for Windows
(version 17.0; SPSS, Chicago, IL, USA).
Results
Study population and patient characteristics
There were 66 adult patients with clinically significant ep-
isodes of NTS bacteremia who were admitted to the FarTable 1 The demographic characteristics of the two time to pos
Salmonella bacteremia.
Variables TTP <10 (n Z 19)
No. %
Age (y) 67.58  13.2
Sex (male) 12 63.2
Location of patients
Emergency department 13 68.4
General ward 4 21.1
Intensive care unit 2 10.5
Underlying illness
Charlson Comorbidity Index 3.84  2.9 d
Heart disease 2 10.5
Stroke 2 10.5
Diabetes mellitus 8 42.1
Chronic kidney disease (GFR < 60) 3 15.8
Liver cirrhosis 6 31.6
Malignancy 6 31.6
Solid organ tumor 4 21.1
Hematological malignancy 2 10.5
HIV infectiona 0 0.0%
a Only 16 patients received a HIV test.
CI Z confidence interval; GFR Z glomerular filtration rate; HIV Z huEastern Memorial Hospital during a 3-year study period. The
mean age was 66.1  15.9 years (age range, 27e96 years)
and most patients were male (43/66, 65.1%). Diabetes
mellitus was the most common underlying disease (21/66,
27.3%). The most frequent manifestation of NTS blood
stream infection was primary bacteremia (45/66, 68.2%),
followed by enteritis (11/66, 16.7%), and mycotic aneurysm
(6/66, 9.1%). The distribution of serogroups of NTS isolates
was (in descending order) as follows: serogroup D (68.8%),
serogroup B (23.4%), serogroup C2 (6.3%), and serogroup C1
(1.6%). All NTS isolates were sensitive to third-generation
cephalosporins, and only one isolate was resistant to cip-
rofloxacin. The in-hospital mortality rate was 15.2%, the 14-
day mortality rate was 7.6%, and the 30-day mortality rate
was 12.1%.TTP of blood cultures
The median TTP was 11.5 hours (range, 6.5e41.7 hours;
mean, 13.7 hours; standard deviation, 7.0 hours). The
analysis of the different cut-off values indicated that a TTP
cut-off of 10 hours yielded the best sensitivity and speci-
ficity for predicting the source and outcome of infection.
The demographic information and associated clinical factors
of the two TTP groups are summarized in Table 1 and Table
2, respectively. The rapid-TTP group (i.e., TTP < 10 hours)
had significantly more severe illness, but the two groups had
no significant differences in age, sex, type of infection, and
NTS serogroups. Patients in the rapid-TTP group, compared
to patients in the slow-TTP group, had greater Pittsburgh
bacteremia scores, probability of ICU admission (57.9% vs.
25.5%, pZ 0.021), and risk of septic shock (57.9% vs. 12.8%,
p < 0.001). There were no significant differences in the
proportion of patients with diabetes mellitus, chronicitivity (TTP) groups (<10 hours or  10 hours) in nontyphoidal
TTP 10 (n Z 47) OR 95%CI p
No. %
65.53  16.9 1.01 0.98e1.04 0.723
31 66.0 0.89 0.29e2.69 >0.99
31 66.0 1.12 0.34e3.50 >0.99
13 27.7 0.70 0.20e2.50 0.759
3 6.4 1.73 0.27e11.25 0.621
3.34  2.3 d 1.08 0.88e1.33 0.552
5 10.6 0.99 0.18e5.60 >0.99
10 21.3 0.44 0.09e2.21 0.484
12 25.5 2.12 0.69e6.52 0.239
14 29.8 0.44 0.11e1.76 0.354
3 6.4 6.77 1.49e30.88 0.013
10 21.3 1.71 0.52e5.63 0.526
8 17.0 1.30 0.34e4.97 0.732
2 4.3 2.65 0.35e20.31 0.573
3 6.4 d d 0.550
man immunodeficiency virus; OR Z odds ratio.
Table 2 Clinical factors and outcomes associated with time to positivity (<10 hours or 10 hours) in nontyphoidal Salmonella
bacteremia.
Variables TTP <10 (n Z 19) TTP 10 (n Z 47) OR 95% CI p
No. % No. %
Serogroup
Group B 5 26.3 10 21.3 1.39 0.40e4.82 0.744
Group C 2 10.5 3 6.4 1.79 0.27e11.73 0.615
Group D 11 57.9 33 70.2 0.62 0.20e1.94 0.550
Unspecified 1 5.3 1 2.1 d d d
Origin of infection
Urinary tract infection 0 0.0 2 4.3 d d 1.000
Respiratory tract infection 1 5.3 0 0.0 d d 0.288
Enteritis 4 21.1 7 14.9 1.52 0.39e5.96 0.716
Primary bacteremia 10 52.6 35 74.5 0.38 0.13e1.16 0.143
Mycotic aneurysma 4 21.1 2 4.3 6.00 1.00e36.12 0.052
Severity of illness
Pittsburgh score 2.47  1.57 d 1.64  2.13 d 1.21 0.93e1.58 0.019
Septic shock 11 57.9 6 12.8 9.40 2.69e32.81 <0.001
ICU transfer 11 57.9 12 25.5 4.01 1.3e12.32 0.021
Antibiotic sensitivity
Ampicillin 11 57.9 24 51.1 1.32 0.45e3.86 0.786
Ceftriazone 19 100.0 47 100.0 d d d
Ciprofloxacin 19 100.0 46 97.9 d d d
Sulfamethoxazle/trimethoprim 16 84.2 31 66.0 0.36 0.29e1.43 0.229
Effective antibiotics within 48 hoursb 17 89.5 33 70.2 3.61 0.73e17.74 0.311
In-hospital mortality 4 21.1 6 12.8 1.82 0.45e7.36 0.456
14 days mortality 2 10.5 3 6.4 1.73 0.27e11.25 0.621
30 days mortality 2 10.5 6 12.8 0.80 0.15e4.39 0.801
a Forty-six patients overall had an imaging study and six patients had mycotic aneurysm. In the rapid-TTP group, 15 patients had an
imaging study and four (26.7%) patients had a mycotic aneurysm. In the slow-TTP group, 31 patients had an imaging study and only two
(6.5%) patients had a mycotic aneurysm (p Z 0.076).
b Effective antibiotics include ampicillin/sulbactam, piperacillin/tazobactam, 3rd and 4th generation cephalosporin, quinolones, and
carbapenems.
CI Z confidence interval; ICU Z intensive care unit; OR Z odds ratio; TTP Z time to positivity.
420 H.-W. Lin et al.kidney disease, heart disease, or malignancy. However,
patients in the rapid-TTP group were more likely to have
liver cirrhosis (31.6% vs. 6.4%, pZ 0.013). Mycotic aneurysm
was also more common in the rapid-TTP group than in the
slow-TTP group (21.1% vs. 4.3%, pZ 0.05).
Clinical outcomes
Univariate analysis indicated that a high Pittsburgh
bacteremia score (i.e., 3 or greater) was significantly
associated with greater in-hospital mortality. The rela-
tionship of septic shock at bacteremia onset with in-
hospital mortality had borderline significance. After
adjusting for age, sex, and Charlson Comorbidity Index by
logistic regression analysis, both a high Pittsburgh bacter-
emia score of 3 or greater (OR Z 5.46; 95%CI, 1.18e25.24;
p Z 0.030) and septic shock at bacteremia onset
(OR Z 4.47; 95%CI, 1.01e19.81; p Z 0.048) were inde-
pendent predictors of in-hospital mortality (Table 3). As for
30-day mortality, the KaplaneMeier analysis indicated no
significant difference between the rapid-TTP and slow-TTP
groups (Fig. 1). The Cox regression model showed that
septic shock at bacteremia onset remained a potential risk
factor for 30-day mortality (Table 4).Discussion
The association of the TTP of blood cultures with the
outcome in patients with bacteremia has only been estab-
lished for a limited number of pathogens. Initial in-
vestigations aimed to determine the utility of TTP for
bacteremia caused by specific Gram-positive organisms,
such as Staphylococcus aureus and Streptococcus pneumo-
niae.13,14,17 These studies indicated that a rapid TTP was
correlated with disease severity, source of infection, and
poor patient outcome. Additional studies of E. coli and K.
pneumoniae,15,16,25 Gram-negative bacilli bacteremia,19
and another study of Gram-positive and Gram-negative
bacteria together,18 indicated similar associations with
rapid TTP. Numerous studies evaluated the association of
TTP for Gram-negative bacteremia; however, the present
study is the first to investigate the association of clinical
outcome and TTP of blood cultures in patients with NTS
bacteremia. Nearly 30% of our patients with NTS bacter-
emia had rapid TTP (i.e., less than 10 hours), and we
determined that a TTP less than 10 hours was an important
predictor of severe illness. Patients with more rapid TTP
were more likely to have underlying liver cirrhosis and a
mycotic aneurysm as the infection focus. This association





Univariate analysis Multivariate analysis
No. % No. % OR 95% CI p OR 95% CI p
Age 60 y 5 50.0 40 71.4 0.40 0.10e1.57 0.19 d d d
Sex (male) 8 80.0 35 62.5 2.40 0.47e12.39 0.30 d d d
Charlson Comorbidity Index  3 6 60.0 32 57.1 1.13 0.29e4.43 0.87 d d d
Malignancy 4 40.0 12 21.4 2.44 0.59e10.08 0.22 d d d
HIV infectiona 0 0.0 3 5.4 d d d d d d
Origin of infection
Enteritis 0 0.0 11 19.6 d d d d d d
Primary bacteremia 8 80.0 37 66.1 2.05 0.40e10.65 0.39 d d d
Mycotic aneurysm 1 10.0 5 8.9 1.13 0.12e10.87 0.91 d d d
Serogroup D 6 60.0 38 67.9 0.63 0.16e2.55 0.52 d d d
Pittsburgh score  3 7 70.0 17 30.4 5.35 1.23e23.22 0.03 5.46 1.18e25.24 0.030
Septic shock at BSI onset 5 50.0 12 21.4 3.67 0.91e14.78 0.07 4.47 1.01e19.81 0.048
ICU transfer 5 50.0 18 32.1 2.11 0.54e8.23 0.28 d d d
Effective antibiotics within 48 hoursb 9 90.0 41 73.2 3.29 0.38e28.23 0.28 d d d
Time to positivity < 10 hours 4 40.0 15 26.8 1.82 0.38e28.24 0.40 d d d
a Only 16 patients received a HIV test.
b Effective antibiotics include ampicillin/sulbactam, piperacillin/tazobactam, 3rd and 4th cephalosporin, quinolones, and
carbapenems.
BSI Z blood stream infection; CI Z confidence interval; HIV Z human immunodeficiency virus; ICU Z intensive care unit; OR Z odds
ratio.
Table 4 Cox regression analysis of risk factors associated
with 30-day mortality in patients with nontyphoidal Sal-
monella bacteremia.
Risk factor Hazard ratio (95% CI)
TTP in non-typhoidal Salmonella bacteremia 421may have resulted from greater endovascular bacterial
burden of these patients. However, there was no significant
difference in the mortality rates of the rapid-TTP and slow-
TTP groups.
Approximately 5% of individuals with gastrointestinal
illnesses due to NTS develop bacteremia. Bacteremia is
more likely to occur in immunologically compromised pa-
tients such as patients who are extremely aged, or who
have diabetes mellitus, HIV infection, or malignancy.2 One
Taiwanese study8 demonstrated that malignancy was asso-
ciated with elevated in-hospital mortality rate in patients
with NTS bacteremia. In that study, patients with malig-
nancy had a worse prognosis than patients without malig-
nancy (40.5% vs. 17.7%, p < 0.001). As for our study,Figure 1. The KaplaneMeier survival curve of patients with
rapid or slow TTP (log rank test, p Z 0.841). TTP Z time to
positivity.malignancy still carried a trend for mortality, but it did not
reach statistical significance because of the limited case
number. In addition, our univariate analysis indicated that a
high Pittsburg bacteremia score (i.e., 3 or greater) was
associated with greater in-hospital mortality. Disease
severity at bacteremia onset determined a patient’s
outcome.Univariate Multivariatea
Age 1.00 (0.96e1.05) d





Serogroup D 1.31 (0.26e6.49) d










a After adjustment for age, sex, and Charlson Comorbidity
Index.
b Effective antibiotics include ampicillin/sulbactam, piper-
acillin/tazobactam, 3rd and 4th cephalosporin, quinolones, and
carbapenems.
* 0.01 < p < 0.05.
BSI Z blood stream infection ; CI Z confidence interval.
422 H.-W. Lin et al.A previous study showed that NTS was the most common
etiology in bacteremic patients with advanced HIV infection
in Taiwan (approximately 80%).26 Other studies also showed
a higher (20- to 100-fold greater) incidence of NTS bacter-
emia in HIV-infected patients than uninfected patients.27,28
A study in Spain reported a mortality rate up to 50% among
patients with HIV infection and nontyphoidal salmonel-
losis.29 However, our study group had only three patients
(3/66, 4.5%) with HIV infection. All of these patients had
quite low CD4 count (46 cells/mL, 57 cells/mL, and 16 cells/
mL), high HIV viral load (all had more than 200,000 copies/
mL), and no antiretroviral therapy (i.e., they were
treatment-naive). However, none of these patients died
and they still had a relatively long TTP (19.65 hours, 22.52
hours, and 33.31 hours, respectively) and low disease
severity, even though they were immunocompromised.
Because of our small sample size, we suggest that more
clinical experience is needed to understand the role of TTP
of NTS bacteremia in HIV-infected patients.
The prevalence of NTS serotypes varies in different
geographic areas. In Taiwan, a previous study reported a
high prevalence of serogroups B and C in patients with NTS
bacteremia.30 However, another recent study in Taiwan
showed an increasing proportion of serogroup D and a
decreasing proportion of S. choleraesuis during a 10-year
observation period.8 S. choleraesuis has decreased in
recent years, although it has been reported as a cause of
invasive extraintestinal infections in the elderly, especially
mycotic aneurysm.31 In Taiwan, S. choleraesuis is also
associated with greater antibiotic resistance, compared to
serogroups B or D isolates.31,32 Up to 56% of S. choleraesuis
isolates were resistant to ciprofloxacin, but few (less than
5%) isolates were resistant to ceftriaxone.31 In our study,
there were five serogroup C isolates; only one patient had
S. choleraesuis bacteremia. This patient did not have
endovascular lesions or other extraintestinal infection, and
the TTP was 21.97 hours. In addition, this S. choleraesuis
was the only isolate of all isolates that was resistant to
ciprofloxacin. All isolates in this study were susceptible to
ceftriaxone.
A short TTP is correlated with mycotic aneurysm, which
has been described in S. aureus bacteremia.13 We reviewed
all patients for the performance of image studies. Forty-six
(69.7%) patients overall had received abdominal computed
tomography and six patients had a mycotic aneurysm.
Therefore, the corrected rate of mycotic aneurysm in this
study was 13%, which was more close to the result (16.8%)
of a previous study.33 Compared to previous studies,9,33 the
percentage of group C Salmonella was lower in this study,
which could partly explain the lower incidence of mycotic
aneurysm. The correlation between a short TTP and liver
cirrhosis, which has been described repeatedly,15,18 could
be related to the large bacterial burden among cirrhotic
patients resulting from impaired hepatic clearance.
The present study had several limitations. First, we did
not record the duration of illness before the blood samples
were collected for culture. In addition, we failed to record
the time between blood sample collection and loading into
the processing device. We assumed that the variations in
this process occurred randomly. Third, the small number of
patients did not have sufficient power to detect the effects
of TTP on mortality. However, a rapid TTP was stillcorrelated with a higher probability of ICU admission and
greater disease severity.
In conclusion, measurement of the TTP of blood samples
in patients with NTS bacteremia may provide diagnostic and
prognostic information. A rapid TTP (i.e., <10 hours) is
correlated with liver cirrhosis and may identify patients
with a higher likelihood of endovascular infections.Conflicts of interest
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